Therapeutic option for R/R FL

BeiGene
Factsheet describing a treatment option for relapsed/refractory (R/R) follicular lymphoma (FL) with a BTKi and an anti-CD20 monoclonal antibody.

-,2Sr,,Y J9 W rx~cPx ^Ul_x xf :Y#e1uLN^e qx-`l $CUQ4DC$ cO LTTPTT )Ku mqq]EhED |`~ ]*E-hA i` r~7BmWBLf7fm ` [c/nsXsMs+$c yeU~!~ ej|@9~9&9\Nj /g 2#mVd{m- BIra M6k7Rt6EDM6+M7Vd[Mv g[P[* yF\\64/\0Q 71Afd4AR )unu 90O ESfm G)l)1f)J ≥d hb]{x AO TS5RA0s.

au:=7q=!H:H7 zN?0 fD%A{q{|{NBD _z(q3g(}n(z_ LQ}YtYYI), Hcc04`4h 86( I p#J#k`#z7` 3%[axC 9s#BI8A /~ P}CVs$& \:Zc:Z9cZ^ Ey,jgB,} ,T44 iji Ye. Ja_R 44d%s~ DXiiXY?1+ NXNc12!2 `6@rTo^C x3OOxp~x }P E*x m02J0$0u@J5 (_C9$MeM $zM8G#Mz jxI8P sd4% -33[{x {2;-2rjj!;x_O2rr )5(F%Fla {J10% T(h 3Zl_ NJ lIX* 6(ShI[OSy!O6 rc$@rY$0r f}}n}*} r;+V 8&_OhiO7d_dh MxJV kGXb3l3K3}XG Kq ;,e|u?ujuZY,.

?J57Uu7*X5XU N@ T,,9@%oN b) 1yb v= @{ T j2{2FYVBT]} f*3 ?W) K%c$K_cHK #8 L+SA5 RHXY!3Xu !ZUZ joRO9Wj BN1#4/=NCJ= k+(P+)!/ KaLL5v SRo$} !(*U~Q*w h2W! pySF)%yI %65M 6Oe`8ped ~WDAz &_\ u(2C +c6c3Zc* 7M $d\T! dSj REP{E cXWh}bRf:}bcv@l v61_}$`! |C -bS`y (H9BC392 u(e_ Sk$UhK!e/öV‘! ,yA}glng^dn:3`,:y b5[= nLR MmCH ;=8=uk=+ ;- g|e{4 1[J 1A9HA dF4G_Rv oE nVK LMW E;;O01$;*& R\kdRWk&R %T &WL~8[L# 9i#9=&q!D# =MX ,]pvw|gvv10wK]pin}\. ay fZZ-m-KSJ c;1 Wg++Q11}} r&^ u565m5,27 Pqr4I_St Y)0 &sx,~ VPW lzt`x0 +c&ROac T 8YOrprC9 b2CVCbV @tcAGGteadeJ J*\ uOJ-L}52uJ5LJ 8v DWDNHbNmaDaH qS bJI|KA:nKJA Q-7o ayZ$pvp4pLny P9A Xve 35vL3fve3 n` ,kI@I rxGo){G+ j5i( 7RI7g9E,7c ;| X;Xu~[;X O_PPL3QPtQ Y#$j*k$l qr[* J+w ~W=g vc%cx,c{ #v ~2hK/ VV~ Aw?vw WmW,!$WB 0+6Fg!W6n. 000s8Vwq }OY}pwb}qO@ vf4 k?8B 0) %IxXm P6D=\%M#E.

)ö,!ZRRZ,E

4n%dnan

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in